# ADC Therapeutics (ADCT) — Analyst Forecast

ADCT · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/adct/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 3 | 1 | 1 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 17, 2026 | Guggenheim | Maintained | Buy | $5.00 |
| Jun 8, 2026 | HC Wainwright & Co. | Downgraded | Buy → Neutral | — |
| Jun 4, 2026 | RBC Capital | Downgraded | Outperform → Sector Perform | $2.00 |
| May 5, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| May 5, 2026 | RBC Capital | Maintained | Outperform | $6.00 |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Oct 16, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Aug 13, 2025 | Guggenheim | Maintained | Buy | $10.00 |
| Jun 20, 2025 | RBC Capital | Maintained | Outperform | $5.00 |
| Jun 13, 2025 | Guggenheim | Maintained | Buy | $10.00 |
| May 15, 2025 | RBC Capital | Maintained | Outperform | $8.00 |
| Mar 31, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Mar 31, 2025 | Guggenheim | Maintained | Buy | $7.00 |
| Mar 7, 2025 | Cantor Fitzgerald | Maintained | Overweight | — |
| Feb 24, 2025 | Stephens & Co. | Maintained | Overweight | $8.00 |
| Jan 6, 2025 | HC Wainwright & Co. | Maintained | Buy | $8.00 |
| Dec 12, 2024 | Guggenheim | Maintained | Buy | $10.00 |
| Dec 11, 2024 | HC Wainwright & Co. | Maintained | Buy | — |
| Nov 8, 2024 | Stephens & Co. | Initiated Coverage | Overweight | $6.00 |
| Aug 8, 2024 | HC Wainwright & Co. | Maintained | Buy | $8.00 |

## Frequently Asked Questions

### Is ADCT a buy, sell, or hold?

Analysts covering ADC Therapeutics currently average a Buy rating: 3 buy, 1 hold and 1 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on ADCT?

On Aug 17, 2026, Guggenheim maintained ADC Therapeutics at Buy with a price target of $5.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).